Review of Moderna's Bird-Flu Vaccine Contract

The U.S. Department of Health and Human Services (HHS) is reviewing a $590 million contract awarded to Moderna for developing a bird-flu vaccine. This review follows concerns about inadequate oversight and the significant impact of the bird-flu outbreak in the U.S., which has led to poultry culling, soaring egg prices, and human infections.